Efficacy and Safety of rhTPO and Eltrombopag in Patients With Primary Immune Thrombocytopenia (ITP)
Condition: Primary Immune Thrombocytopenia Interventions: Drug: rhTPO; Drug: eltrombopag Sponsors: Wuhan Union Hospital, China; The First Affiliated Hospital of Nanchang University; The Third Xiangya Hospital of Central South University; The First People's Hospital of Yuhang District; Xiangyang Central Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials